Projects per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicine & Life Sciences
Methotrexate
Medicine & Life Sciences
Pediatrics
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Leukemia
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Peter Cole
- Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology - PROF-TT-DIV CHIEF
- Clinical Investigations and Precision Therapeutics Program, CINJ - FULL MEMBER
Person
Richard Drachtman
- Cancer Institute of New Jersey (CINJ), Pediatric Hematology/Oncology - PROF-CLIN-DIV CHIEF
- Clinical Investigations and Precision Therapeutics Program, CINJ - ASSOCIATE MEMBER
Person
Projects 2014 2023
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL
Cole, P. & Sands, S. A.
9/17/18 → 8/31/23
Project: Research project
Secondary Prevention
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Therapeutics
Oxidative Stress
Cognition
The multifaceted role of the Fanconi anemia tumor suppressor pathway in facilitating DNA replication
4/1/17 → 8/31/21
Project: Research project
Fanconi Anemia
DNA Replication
Fanconi Anemia Complementation Group Proteins
Hematopoietic Stem Cells
Neoplasms
Markers of Cognitive Decline During Treatment for Childhood ALL
Cole, P. & Sands, S. A.
9/17/15 → 6/30/18
Project: Research project
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Secondary Prevention
Cognition
Therapeutics
Leukemia
Research Output 1991 2019
2
Citations
(Scopus)
Association of Combined Modality Therapy vs Chemotherapy Alone with Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma
Jhawar, S. R., Rivera-Núñez, Z., Drachtman, R., Cole, P. D., Hoppe, B. S. & Parikh, R. R., May 2019, In : JAMA Oncology. 5, 5, p. 689-695 7 p.Research output: Contribution to journal › Article
Combined Modality Therapy
Hodgkin Disease
Pediatrics
Drug Therapy
Survival
Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation
Brace, K. M., Lee, W. W., Cole, P. D. & Sussman, E. S., Sep 14 2019, In : Journal of Clinical and Experimental Neuropsychology. 41, 8, p. 814-831 18 p.Research output: Contribution to journal › Article
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Evoked Potentials
Leukemia
Drug Therapy
Brain
1
Citation
(Scopus)
Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort
Ladas, E. J., Orjuela, M., Stevenson, K., Cole, P. D., Lin, M., Athale, U. H., Clavell, L. A., Leclerc, J. M., Laverdiere, C., Michon, B., Schorin, M. A., Welch, J. G., Asselin, B. L., Sallan, S. E., Silverman, L. B. & Kelly, K. M., Dec 2019, In : Clinical Nutrition. 38, 6, p. 2866-2874 9 p.Research output: Contribution to journal › Article
Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nutrition Surveys
Pediatrics
Therapeutics